Investigator Initiated, Placebo Controlled, Randomized Pilot Trial on the Influence of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in Smokers With COPD Stage GOLD 0 or 1.
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2010
At a glance
- Drugs Fluticasone propionate; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 14 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 May 2009 New trial record